Shares of Document Security Systems, Inc. (NYSE: DSS) today surged 5.16% after announcing that one of its subsidiaries Impact BioMedical, Inc. had completed the efficacy testing of its proprietary 3F Antiviral Biofragrance (“3F Biofragrance) at a biosafety level 3 containment facility at an independent university.
The study was conducted by Global BioLife, Inc., a subsidiary of Impact BioMedical Inc., which in turn is a fully owned subsidiary of DSS.
The study demonstrated a 10-fold reduction in COVID-19 viral population on surfaces using 3F Biofragrance. The study also proved that 3F Biofragrance was an effective surface disinfectant that kills the COVID-19 virus even in concentrations as low as 1/5000 or 0.02%.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Daryl Thompson, Global BioLife’s Director of Scientific Initiatives stated: “We’re extremely excited with the results of the study, which was based on a quantifiable, robust model and designed to treat high levels of the COVID-19 virus,”
Adding that:
“3F Biofragrance has the potential to transform typical consumer products into weapons against the spread of COVID-19 and other viruses, and we look forward to providing updates on ongoing negotiations for global licensing and royalty agreements of this innovative technology,”
DSS share price
DSS shares today surged 5.16% to trade at $5.94 premarket having ended Wednesday’s session trading at $5.62.
People who read this also read:
